A Study to Assess S011806 (DC-806 or LY4100504) in Healthy Adult Participants and Participants With Chronic Plaque Psoriasis

NCT06808815 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis

Interventions

DRUG: DC-806
OTHER: Placebo

Sponsor

DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company